Delivery Order SPE2DB22D3016-SPE2DB24FAYQ1

Award Date 6/17/24
Potential Completion Date 7/10/24
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $18,559.58. The contract is for the supply of the pharmaceutical product Lenvima 14 mg daily dose, with a completion date of June 5, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Lenvima 14 mg daily dose 60-count pharmaceutical products. The $19,821.90 firm fixed-price delivery order contract has an ultimate completion date of December 20, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $15,485.41 for the supply of LENVIMA 10 MG DAILY DOSE 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 19, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The $9,279.78 firm fixed price delivery order is for the supply of the pharmaceutical product LENVIMA 14 MG DAILY DOSE 60S. The award has an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of LENVIMA 14 MG DAILY DOSE 60S, a specialty pharmaceutical product. The award has a firm fixed price of $9,910.95 and an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of the drug Lenvima 8 mg, with a completion date of August 2, 2024. The $19,159.72 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a major defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. As a subsidiary of the large pharmaceutical distributor Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $9,579.86 and is for the delivery of LENVIMA 14 MG DAILY DOSE 60S pharmaceutical products. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
This federal contract award, valued at $9,910.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LENVIMA 14 MG DAILY DOSE 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of February 19, 2025. This award does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.95 fixed-price delivery order is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,910.95 firm fixed-price contract is for the supply of LENVIMA 8 MG DAILY DOSE 60S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and was awarded on December 2, 2024. No set-aside designation was used. AmerisourceBergen holds a significant...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAYQ1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product LENVIMA 14 MG DAILY DOSE 60S to the Defense Logistics Agency (DLA), a defense agency. The firm-fixed-price delivery order, valued at $9,579.86, has a completion date of July 10, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 9/16/24, 10:42 AM